Navigation Links
High Demand for Weight Mgmt Product in European Pharmacies

Following completion of an exclusive Distribution Agreement with Laboratoire Physcience, France, for the rights to market LTP's satiety ingredient Olibra(R)//, as a single dose mini-shot, in France, Belgium, Spain, and Portugal, Physcience has successfully launched its Slim 10/10 product into these markets.

‘This is our most successful ever product launch into the French market, we have never seen such a success,’ says Jean Saint-Cricq, CEO Laboratoire Physcience. ‘During the quarter January/March 2006, Nielsen data has positioned Slim 10/10 as the lead product in terms of demand within the weight management category, throughout French pharmacies.

‘We have had such a positive response to Slim 10/10, from Health Professionals, Journalists and the trade sector. Our extensive above and below the line marketing support for the launch of Slim 10/10, including National TV campaigns throughout the whole of the launch period, has created high visibility & awareness of the brand.’

Slim 10/10 was successfully introduced in three other European countries: to date, Slim 10/10 is on shelf in 1600 pharmacies in Spain and at key retailers such as El Corte Ingles, in 1200 pharmacies in Belgium and in 400 pharmacies in Portugal.

Slim 10/10(TM) is a single effective 7.5g dose of Olibra(R), a natural ingredient, which can be safely taken orally, or added to normal food, taken at breakfast and/or lunch. The single dose product is packed in convenient strips for easy use.

LTP's functional food ingredient, Olibra(R), which addresses weight management, is derived from palm oil and oat oil. When applied as a food ingredient, the product has a scientifically substantiated effect of prolonging the feeling of fullness, resulting in significant reductions in energy intake at subsequent meals.

Source: PTI nes

Page: 1

Related medicine news :

1. High Demand for a child vaccine
2. Demand for universal flu vaccination
3. Mentally Demanding Jobs Found To Reduce The Risk Of Alzheimer’
4. Research Fraud By Doctor – Probe Demanded
5. Drugs Manufacturers Capitalizing On The Surge In Demand For Bone Health Care
6. Bird Flu Likely To Reduce World Energy Demand
7. New Plastic Surgery Unit Set Up In Kolkata To Meet Ever-Increasing Consumer Demand
8. Sex Health Clinics Unable To Meet Increasing Demand
9. Bird Flu Scare Does Not Reduce Demand For Chicken
10. Demand For Diet Drugs On The Rise
11. High Demand For Circumcision In AIDS-Hit Swaziland
Post Your Comments:

(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a ... can give their videos a whole new perspective by using the title layers ... Film Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... HILLS, Calif. , June 23, 2016 Any ... the many challenges of the current process. Many of them ... because of the technical difficulties and high laboratory costs involved. ... have to offer it at such a high cost that ... afford it. Dr. Parsa Zadeh , founder ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
Breaking Medicine Technology: